Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...
The prospective, epidemiologic School Inner-City Asthma Study (SICAS) evaluated potential biomarkers of inflammation associated with radon exposure among children aged 4 to 13 years with persistent ...
Zacks Small Cap Research on MSN4d
SNGX: Preclinical Data Shows CiVax™ Booster Induces Broad Protection Against COVID-19…SNGX READ THE FULL SNGX RESEARCH REPORT Business Update CiVax™ Booster Enhances Protection from COVID-19 in NHPs On March 25, ...
Laboratoire de Spectrométrie de Masse BioOrganique, CNRS, Université de Strasbourg, IPHC UMR 7178, Infrastructure Nationale de Protéomique ProFI - FR2048, 67087 Strasbourg, France ...
TFE3 fusion proteins are the oncogenic drivers of translocation renal cell carcinoma but their mechanism of action remains ...
The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.
Analyses of the manufacturer's more extensive data yielded similar results. The assay was reworked as a consequence, but was not removed from other markets during the interim period. NRL ...
The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...
City Pulse Multiplex Ltd., incorporated in the year 2000, is a Small Cap company (having a market cap of Rs 1,312.32 Crore) operating in Media & Entertainment sector. City Pulse Multiplex Ltd. key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback